Weizmann institute of science
Rehovot, Israel
Location status: Recruiting
NCT Number: NCT05817734
This is a prospective study aimed at recruiting 30,000 individuals, aged 40-70 years old, and following them longitudinally for 25 years with repeated measurements. The basic follow-up frame will include a visit to the Clinical Test Center (CTC) every two years and a phone interview every other year (on uneven years). Sample collection and biobanking will be performed every two years and online questionnaires will be filled out on an annual basis.
The primary goals are to study the variation observed across different individuals in disease susceptibility, clinical phenotypes, and therapeutic responses. The study aims at studying the complex interplay and relative contribution of different omics, physiological characteristics and lifestyle on disease pathogenesis and progression and to evaluate how these effects are mediated.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Rehovot, Israel
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 25 years
Development of medical conditions based on participant's self-reporting coded to ICD11.
Contact information is provided by the study sponsor or research team.
Weizmann Institute of Science
Other
Longitudinal Collection of Observational Clinical and Lifestyle Data
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06007092
Adult Disease, Disease
Villejuif, France
View Trial DetailsNCT06403436
Adult Disease, Adult Solid Tumor
Nashville, Tennessee, United States
View Trial DetailsNCT04643015
Adult Disease, Disease
New York, United States
View Trial DetailsNCT05578872
Adult Disease, Advanced Solid Tumor
Birmingham, Alabama, United States
View Trial Details